Australian Clinical Labs Ltd (AU:ACL) has released an update.
Mitsubishi UFJ Financial Group, Inc. has ceased to be a substantial holder in Australian Clinical Labs Limited, as detailed in a Form 605 filing dated 31 May 2024. The document outlines a series of changes in relevant interests, including both purchases and sales of voting securities by entities controlled by major financial firms such as Morgan Stanley. These transactions involve varying numbers of fully paid ordinary shares and reflect the dynamic nature of stock market investments.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
